Literature DB >> 34199525

Active Human and Murine Tumor Necrosis Factor α Cytokines Produced from Silkworm Baculovirus Expression System.

Takeru Ebihara1, Jian Xu2, Yoshino Tonooka1, Takumi Nagasato1, Kohei Kakino1, Akitsu Masuda1, Kosuke Minamihata3, Noriho Kamiya3,4, Hirokazu Nakatake5, Yuuka Chieda5, Hiroaki Mon1, Tsuguru Fujii6, Takahiro Kusakabe1, Jae Man Lee6.   

Abstract

The tumor necrosis factor α (TNFα) has been employed as a promising reagent in treating autoimmunity and cancer diseases. To meet the substantial requirement of TNFα proteins, we report in this study that mature types of recombinant human and murine TNFα proteins are successfully expressed in the baculovirus expression system using silkworm larvae as hosts. The biological activities of purified products were verified in culture murine L929 cells, showing better performance over a commercial Escherichia coli-derived murine TNFα. By comparing the activity of purified TNFα with or without the tag removal, it is also concluded that the overall activity of purified TNFα cytokines could be further improved by the complete removal of C-terminal fusion tags. Collectively, our current attempt demonstrates an alternative platform for supplying high-quality TNFα products with excellent activities for further pharmaceutical and clinical trials.

Entities:  

Keywords:  TNFα; baculovirus; protein purification; silkworm expression system

Year:  2021        PMID: 34199525     DOI: 10.3390/insects12060517

Source DB:  PubMed          Journal:  Insects        ISSN: 2075-4450            Impact factor:   2.769


  2 in total

1.  A De Novo Optimized Cell-Free System for the Expression of Soluble and Active Human Tumor Necrosis Factor-Alpha.

Authors:  Nawal Abd El-Baky; Esmail M El-Fakharany; Soraya A Sabry; Ehab R El-Helow; Elrashdy Mustafa Redwan; Amira Sabry
Journal:  Biology (Basel)       Date:  2022-01-19

2.  Expression and Purification of Porcine Rotavirus Structural Proteins in Silkworm Larvae as a Vaccine Candidate.

Authors:  Tatsuya Kato; Tatsuki Kakuta; Ami Yonezuka; Tomofumi Sekiguchi; Yuki Machida; Jian Xu; Tohru Suzuki; Enoch Y Park
Journal:  Mol Biotechnol       Date:  2022-08-13       Impact factor: 2.860

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.